{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:21:45Z","timestamp":1791357705685,"version":"4.3.1"},"reference-count":40,"publisher":"Society of Nuclear Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.2967\/jnumed.120.255968","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T20:20:20Z","timestamp":1615580420000},"page":"1163-1170","source":"Crossref","is-referenced-by-count":9,"title":["Mapping Arginase Expression with <sup>18<\/sup>F-Fluorinated Late-Generation Arginase Inhibitors Derived from Quaternary \u03b1-Amino Acids"],"prefix":"10.2967","volume":"62","author":[{"given":"Gon\u00e7alo S.","family":"Clemente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas F.","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Kurhade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariska P.M.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen W.A.","family":"Sijbesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aren","family":"van Waarde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogier C.","family":"Buijsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Willemsen-Seegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinoud","family":"Gosens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Meurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"D\u00f6mling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip H.","family":"Elsinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"2021090907551061000_62.8.1163.1","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3389\/fimmu.2014.00544","article-title":"Evolutionary roots of arginase expression and regulation","volume":"5","author":"Dzik","year":"2014","journal-title":"Front Immunol"},{"key":"2021090907551061000_62.8.1163.2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1152\/physrev.00037.2016","article-title":"Arginase: a multifaceted enzyme important in health and disease","volume":"98","author":"Caldwell","year":"2018","journal-title":"Physiol Rev"},{"key":"2021090907551061000_62.8.1163.3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.exger.2018.12.011","article-title":"The role of arginase in aging: a systematic review","volume":"116","author":"Moretto","year":"2019","journal-title":"Exp Gerontol"},{"key":"2021090907551061000_62.8.1163.4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.drudis.2018.01.046","article-title":"Research of novel anticancer agents targeting arginase inhibition","volume":"23","author":"Pham","year":"2018","journal-title":"Drug Discov Today"},{"key":"2021090907551061000_62.8.1163.5","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.3390\/ijms21155291","article-title":"Arginase as a potential biomarker of disease progression: a molecular imaging perspective","volume":"21","author":"Clemente","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2021090907551061000_62.8.1163.6","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/all.13770","article-title":"Recent patents in allergy\/immunology: use of arginase inhibitors in the treatment of asthma and allergic rhinitis","volume":"74","author":"Meurs","year":"2019","journal-title":"Allergy"},{"key":"2021090907551061000_62.8.1163.7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/med.21419","article-title":"Arginase inhibitors: a rational approach over one century","volume":"37","author":"Pudlo","year":"2017","journal-title":"Med Res Rev"},{"key":"2021090907551061000_62.8.1163.8","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.119.264341"},{"key":"2021090907551061000_62.8.1163.9","unstructured":"Van Zandt M Golebiowski A JI MK Whitehouse D Ryder T Beckett P inventors; Mars, Inc., assignee. Inhibitors of arginase and their therapeutic applications. U.S. patent application WO\/2011\/133653. October 27, 2011."},{"key":"2021090907551061000_62.8.1163.10","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1016\/j.bmcl.2013.06.092","article-title":"Synthesis of quaternary \u03b1-amino acid-based arginase inhibitors via the Ugi reaction","volume":"23","author":"Golebiowski","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"2021090907551061000_62.8.1163.11","doi-asserted-by":"crossref","first-page":"1536012117717852","DOI":"10.1177\/1536012117717852","article-title":"Molecular imaging of hydrolytic enzymes using PET and SPECT","volume":"16","author":"Rempel","year":"2017","journal-title":"Mol Imaging"},{"key":"2021090907551061000_62.8.1163.12","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.bmcl.2013.02.024","article-title":"2-substituted-2-amino-6-boronohexanoic acids as arginase inhibitors","volume":"23","author":"Golebiowski","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"2021090907551061000_62.8.1163.13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1021\/acsmedchemlett.9b00508","article-title":"Discovery and pharmacokinetics of sulfamides and guanidines as potent human arginase 1 inhibitors","volume":"11","author":"Blaszczyk","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"2021090907551061000_62.8.1163.14","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1002\/chem.201604633","article-title":"Alcohol-enhanced Cu-mediated radiofluorination","volume":"23","author":"Zischler","year":"2017","journal-title":"Chemistry"},{"key":"2021090907551061000_62.8.1163.15","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/molecules24071327","article-title":"MCR scaffolds get hotter with 18F-labeling","volume":"24","author":"Zarganes-Tzitzikas","year":"2019","journal-title":"Molecules"},{"key":"2021090907551061000_62.8.1163.16","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.3390\/molecules24234210","article-title":"Late-stage copper-catalyzed radiofluorination of an arylboronic ester derivative of atorvastatin","volume":"24","author":"Clemente","year":"2019","journal-title":"Molecules"},{"key":"2021090907551061000_62.8.1163.17","first-page":"100014","article-title":"Structural insights into human arginase-1 pH dependence and its inhibition by the small molecule inhibitor CB-1158","volume":"4","author":"Grobben","year":"2019","journal-title":"J Struct Biol X"},{"key":"2021090907551061000_62.8.1163.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2003.10.012"},{"key":"2021090907551061000_62.8.1163.19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mce.2007.12.015","article-title":"Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment","volume":"284","author":"Sigala","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"2021090907551061000_62.8.1163.20","first-page":"357","article-title":"Expression of arginase II in prostate cancer","volume":"32","author":"Mumenthaler","year":"2008","journal-title":"Int J Oncol"},{"key":"2021090907551061000_62.8.1163.21","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-5-17"},{"key":"2021090907551061000_62.8.1163.22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055146"},{"key":"2021090907551061000_62.8.1163.23","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.144"},{"key":"2021090907551061000_62.8.1163.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00374.x"},{"key":"2021090907551061000_62.8.1163.25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00057710"},{"key":"2021090907551061000_62.8.1163.26","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0285"},{"key":"2021090907551061000_62.8.1163.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2010.02.004"},{"key":"2021090907551061000_62.8.1163.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(97)00099-1"},{"key":"2021090907551061000_62.8.1163.29","unstructured":"The Human Protein Atlas website. http:\/\/www.proteinatlas.org. Accessed March 29, 2021."},{"key":"2021090907551061000_62.8.1163.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00360-003-0407-z"},{"key":"2021090907551061000_62.8.1163.31","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-016-0381-y"},{"key":"2021090907551061000_62.8.1163.32","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2967\/jnumed.119.240895","article-title":"Quantification of PD-L1 expression with 18F-BMS-986192 PET\/CT in patients with advanced stage non-small-cell lung cancer","volume":"61","author":"Huisman","year":"2020","journal-title":"J Nucl Med"},{"key":"2021090907551061000_62.8.1163.33","first-page":"137","article-title":"Susceptibility to hydrolysis of phenylboronic pinacol esters at physiological pH","volume":"11","author":"Achilli","year":"2013","journal-title":"Cent Eur J Chem"},{"key":"2021090907551061000_62.8.1163.34","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.210138"},{"key":"2021090907551061000_62.8.1163.35","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200710-1542OC"},{"key":"2021090907551061000_62.8.1163.36","doi-asserted-by":"crossref","first-page":"e0183066","DOI":"10.1371\/journal.pone.0183066","article-title":"Arginine metabolic endotypes related to asthma severity","volume":"12","author":"Xu","year":"2017","journal-title":"PLoS One"},{"key":"2021090907551061000_62.8.1163.37","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2010.512037"},{"key":"2021090907551061000_62.8.1163.38","doi-asserted-by":"crossref","first-page":"2760S","DOI":"10.1093\/jn\/134.10.2760S","article-title":"Structure and function of arginases","volume":"134(suppl)","author":"Ash","year":"2004","journal-title":"J Nutr"},{"key":"2021090907551061000_62.8.1163.39","first-page":"1409","article-title":"Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor","volume":"290","author":"Baggio","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2021090907551061000_62.8.1163.40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2217\/imt-2016-0118","article-title":"Modulation of cancer-specific immune responses by amino acid degrading enzymes","volume":"9","author":"Timosenko","year":"2017","journal-title":"Immunotherapy"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.255968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T15:01:53Z","timestamp":1631199713000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.255968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,7,30]]},"published-print":{"date-parts":[[2021,8,1]]}},"alternative-id":["10.2967\/jnumed.120.255968"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.255968","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]}}}